4th Quarter - Report

AVENUE SOLUTIONS for MERCK & CO. INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Inflation Reduction Act of 2022 (PL 117-169) implementation - creating Medicare negotiation of drugs, creating a new inflation rebate under Medicare, limiting insulin copays to $35/month, capping Medicare Part D premium growth, expanding premium and co-pay assistance on prescription drugs for low-income individuals, and capping Medicare out of pocket costs at $2,000 per year, and preventing commercial spillover of maximum fair price into markets beyond Medicare; Consolidated Appropriations Act, 2023 (PL 117-328)- allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF), preserving coverage and access to Part D products under EUA; Antibiotics/stewardship; Value of prescription drugs; S. 2076/H.R. 3932, PASTEUR Act of 2021; ACIP recommendations related to pneumococcal vaccines; S. 3700/H.R. 6833, Affordable Insulin Now Act; Issues related to reauthorization of FDA user fee bills (H.R.7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to the White House Cancer Moonshot initiative; S. 2706/H.R. 5030, DIVERSE Trials Act; Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act; Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2076 (117th), S. 4348 (117th), H.R. 3932 (117th), S. 2706 (117th), H.R. 5030 (117th), H.R. 7667 (117th), H.R. 6833 (117th), S. 3700 (117th)

Medicare/Medicaid MMM

Issues relating to the further development of antibiotics and antimicrobials for serious and unmet medical needs; Antibiotics/stewardship; S.2076/H.R.3932, PASTEUR Act of 2021; Value of prescription drugs; Issues related to Medicare Parts B and D; Issues related to Vaccine Injury Compensation Fund (VICF); Issues related to coverage of EUA products in Part D

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2076 (117th), H.R. 3932 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.